Eli Lilly

Lilly Puts Potential $660M on the Line for Protein-Protein Interaction Blockers
Lilly Puts Potential $660M on the Line for Protein-Protein Interaction Blockers
BioSpace
Eli Lilly
PRISM BioLab
small molecule inhibitors
Flag link:
Teva drops patent case against Lilly after two Ajovy patents deemed invalid
Teva drops patent case against Lilly after two Ajovy patents deemed invalid
Fierce Pharma
Teva Pharmaceutical
legal
Eli Lilly
Ajovy
patents
migraines
Flag link:
Eli Lilly supports Alto Neuroscience in $45m Series C round
Eli Lilly supports Alto Neuroscience in $45m Series C round
Clinical Trials Arena
Eli Lilly
Alto Neuroscience
funding
psychiatric diesase
Flag link:
The Next Generation of Weight Loss Drugs is Rapidly Approaching
The Next Generation of Weight Loss Drugs is Rapidly Approaching
BioSpace
weightloss
Novo Nordisk
Eli Lilly
Pfizer
AstraZeneca
Wegovy
Zepbound
Flag link:
Manufacturer Lonza says it will not fill obesity drug syringes
Manufacturer Lonza says it will not fill obesity drug syringes
Reuters
Lonza
drug manufacturing
obesity
Novo Nordisk
Eli Lilly
Flag link:
Why Eli Lilly Stock Flopped While the Market Popped Today
Why Eli Lilly Stock Flopped While the Market Popped Today
Motley Fool
Eli Lilly
Europe
drug manufacturing
Flag link:
Novo Nordisk fights back at Lilly with Wegovy combo trial against Zepbound in obesity
Novo Nordisk fights back at Lilly with Wegovy combo trial against Zepbound in obesity
https://bit.ly/49zNkYL
Novo Nordisk
Eli Lilly
clinical trials
CagriSema
Wegovy
Zepbound
obesity
Flag link:
Lilly, UCB-Backed ViaNautis Scores $25M for Genetic Nanomedicines
Lilly, UCB-Backed ViaNautis Scores $25M for Genetic Nanomedicines
BioSpace
ViaNautis Bio
Eli Lilly
genetic nanomedicine
UCB Pharma
funding
Flag link:
AHA: One dose of Lilly’s siRNA drug cuts Lp(a) for a year
AHA: One dose of Lilly’s siRNA drug cuts Lp(a) for a year
Pharmaphorum
Eli Lilly
AHA
siRNA
lipoprotein(a)
cardiovascular disease
lepodisiran
Flag link:
Lilly’s Zepbound vs. Novo’s Wegovy: The Weight-Loss Drug Race Has Officially Started
Lilly’s Zepbound vs. Novo’s Wegovy: The Weight-Loss Drug Race Has Officially Started
Motley Fool
Eli Lilly
Zepbound
Novo Nordisk
Wegovy
weightloss
Flag link:
Eli Lilly Was Hoping for 5 Big Drug Launches This Year. Here's How It Has Done Thus Far.
Eli Lilly Was Hoping for 5 Big Drug Launches This Year. Here's How It Has Done Thus Far.
Motley Fool
Eli Lilly
donanemab
tirzepatide
mirikizumab
lebrikizumab
pirtobrutinib
Flag link:
How Eli Lilly’s obesity drug Zepbound is poised to reshape pharma markets
How Eli Lilly’s obesity drug Zepbound is poised to reshape pharma markets
Medical Marketing and Media
Eli Lilly
tirzepatide
weightloss
Zepbound
Mounjaro
Flag link:
FDA Approves Eli Lilly’s Zepbound for Chronic Weight Management
FDA Approves Eli Lilly’s Zepbound for Chronic Weight Management
BioSpace
Eli Lilly
Zepbound
FDA
weightloss
Flag link:
An obesity drug biotech gets buy-in from Eli Lilly, venture firms
An obesity drug biotech gets buy-in from Eli Lilly, venture firms
BioPharma Dive
OrsoBio
Eli Lilly
funding
obesity
diabetes
Flag link:
Novo, Lilly Weight-Loss Drug Juggernaut Has Nowhere to Go But Up
Novo, Lilly Weight-Loss Drug Juggernaut Has Nowhere to Go But Up
BioSpace
Novo Nordisk
Eli Lilly
Wegovy
Mounjaro
weightlosss
Flag link:
Eli Lilly Just Added Another Potential Billion-Dollar Product
Eli Lilly Just Added Another Potential Billion-Dollar Product
Motley Fool
Eli Lilly
ulcerative colitis
Omvoh
Flag link:
Lilly's blockbuster Mounjaro boosts third quarter results, supply issues persist
Lilly's blockbuster Mounjaro boosts third quarter results, supply issues persist
Reuters
Eli Lilly
earnings
Mounjaro
Flag link:
Eli Lilly, Redwire head to space to explore next frontier of drug development
Eli Lilly, Redwire head to space to explore next frontier of drug development
Fierce Pharma
Eli Lilly
drug development
Redwire
PIL-BOX
in-space manufacturing
Flag link:
Lilly buys Beam’s option on Verve drug programs
Lilly buys Beam’s option on Verve drug programs
Pharmaforum
Eli Lilly
gene editing
Beam Therapeutics
Verve Therapeutics
Flag link:
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
Motley Fool
Roche
Eli Lilly
Pfizer
IBD
ulcerative colitis
Crohn's Disease
mirikizumab
Flag link:

Pages